Trading Options with an Edge
Select Page

TRIL

Search by
TICKER SYMBOL

Trillium Therapeutics Inc

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

18.44

0

(0%)

Volume:

0

52 week range:

0 - 18.44

Market Cap:

1.936B

Company Description:

Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune system.